Key Highlights
•
For patients with medium or distal vessel occlusion stroke, endovascular treatment plus best medical treatment did not reduce disability or death at 12 months compared to best medical treatment alone. These results confirm that routine endovascular treatment is not supported for patients with mild-to-moderate strokes of this type.
Source →
•
A new digital seed amplification assay (dSAA) can precisely quantify TDP-43 protein aggregates in cerebrospinal fluid, with elevated seed concentrations found in patients with frontotemporal lobar dementia. This breakthrough offers a sensitive diagnostic tool for TDP-43-related diseases, which are common causes of dementia and often misdiagnosed without biomarkers.
Source →
•
The CORRECT-BD trial compared right unilateral ultrabrief electroconvulsive therapy (ECT) versus magnetic seizure therapy (MST) for bipolar depression, examining clinical and cognitive outcomes. This research directly addresses the need for safer and more effective brain stimulation treatments for mood disorders.
Source →
•
Radiotherapy followed by adjuvant temozolomide significantly improves survival for patients with aggressive IDH-mutated anaplastic glioma, a type of brain cancer. This finding provides a clear treatment pathway for a condition with historically poor outcomes.
Source →
•
Reeler mice, a model for studying brain development, show impaired performance in a texture-based novelty recognition task, revealing deficits in learning and memory linked to neuronal migration disorders. This work sheds light on the fundamental mechanisms of neurodevelopmental disorders.
Source →
Stay curious. Stay informed —
Science Briefing
